The effect of human fibroblast interferon (IFN), a heterologous IFN, on the uncoating of murine leukaemia virus (MLV) was investigated in exogenously infected NIH/3T 3 mouse cells. Virus uncoating was determined by following the disappearance of the penetrating virus particles from the cytoplasm of the infected cells. Intracellular virus particles were estimated by sedimenting them at high speed from the cytoplasmic fraction of the infected cells and assaying their reverse transcriptase activity. In untreated control cells, uncoating started immediately after penetration, but in cells treated with human IFN, uncoating was delayed for 2 to 3 h. This delay led to prolongation of the infectious cycle, with delayed release of progeny virus. The delay in release did not result from inhibition by IFN of the process of release, since in NIH/3T3 cells chronically infected with MLV, treatment with IFN had no effect on virus release.
Interferon (IFN) is known to inhibit the replication of retroviruses in exogenously, endogenously and chronically infected cells (for reviews, see Billiau, 1977; Friedman, 1977) . We have recently found that in exogenous infection of mouse cells by murine leukaemia virus (MLV), mouse IFN inhibits virus uncoating (Aboud et al. 198o ). This inhibitory effect of IFN was observed even after IFN treatment for as little as 3o rain and furthermore, was independent of cellular protein synthesis. In these respects, this effect therefore differs from the usual IFN-mediated antiviral state, which requires several hours for full establishment and strictly depends on cellular protein synthesis. In contrast, the binding of IFN to the cell surface is rapid and requires no cellular metabolic activities (Friedman, I977) . We have therefore suggested that the effect of IFN on MLV uncoating results from the mere binding of IFN to the cell membrane.
The establishment of IFN-mediated antiviral state is known to be a relatively speciesspecific process (Friedman, I977, 1978) , whereas the binding of IFN to membrane receptors is much less species-specific (Besanqon & Ankel, I977; Chany, I976) . If the binding of IFN to the cell surface is indeed sufficient for the inhibition of MLV uncoating, it would be expected that this effect be exerted even by heterologous IFNs. To examine this possibility the effect of human fibroblast IFN on MLV uncoating in NIH/3T 3 mouse cells was studied. The cells were plated at a density of 2"5 × IO 6 cells per 9 cm Petri dish (Nunc, Denmark) with or without 8o international units (iu)/ml human IFN I6 h before infection. This IFN preparation contained 5 x io 5 iu/mg protein and was kindly provided by M. Revel of the Weizmann Institute of Science, Rehovot, Israel. Mouse IFN, used in some control experiments, contained 1o 5 iu/mg protein and was prepared as described elsewhere (Aboud et al. 1976 ) . Stocks of infectious MLV for exogenous infections were prepared from MLVchronically infected NIH/3T3 [NIH/3T3(MLV)] ceils as previously described (Aboud et al. 1979 )-Virus uncoating was determined by following the disappearance of intracellular virus particles estimated by their reverse transcriptase activity as described in a previous report (Aboud et al. I979) . To investigate the effect of human IFN on MLV uncoating, IFN-treated and untreated NIH/3T3 cells were infected with MLV for 30 min. Unadsorbed virus was removed and the cells were further incubated with a fresh IFN-free medium. At various times after infection the cells were dispersed by 0"4 ~ trypsin to destroy residual external virions and analysed for intracellular virus particles. The results presented in Fig. I show that, while intracellular virus particles started to disappear gradually from the cytoplasm of the control cells shortly after their penetration, their level remained stable for 2 to 3 h in the IFN-treated cells. This finding strongly suggests that human IFN, like mouse IFN (Aboud et al. I98o) , inhibits MLV uncoating in mouse cells.
It was of interest to elucidate whether this delay in virus Uncoating would result in a similar delay in the final release of virus progeny. For this purpose NIH/3T3 cells were plated in the presence of 80 iu/ml human IFN or, for comparison, with 80 iu/ml mouse IFN. Cells plated without IFN served as a control. After I6 h the ceils were infected with MLV for I h. Unadsorbed virus was removed and the cells were further incubated with a fresh IFN-free medium. The release of progeny virus was followed by analysing virusassociated reverse transcriptase activity in aliquots taken from the culture medium at various times after infection. It can be seen from the results presented in Fig. 2 that both species of IFN caused a significant delay in the time when release of virus progeny began, although mouse IFN had the greater effect.
Mouse IFN also inhibits late steps of MLV replication (Billiau, I977; Friedman, 1977 ). This effect is most probably related to the usual IFN-induced antiviral state, since its establishment requires several hours (Salzberg et al. 1978; Pitha et al. I979 )-It was thus important to verify that the effect of human IFN on the final release of MLV resulted only from its early effect and not from inhibition of the release itself. We elucidated this aspect by examining the effect of human IFN on virus release from chronically infected NIH/ 3T3(MLV) cells in which no early step before integration of virus DNA into the host genome takes place. Thus NIH/3T3(MLV ) cells were plated with 80 iu/ml human IFN, or for comparison, with 80 iu/ml mouse IFN. Cells plated without IFN served as a control. After I6 h the cells were washed and further incubated with fresh IFN-free medium. Virus release was followed by assaying virus reverse transcriptase activity in aliquots taken from the culture medium at various times afterwards. The results shown in Fig. 2 (b) clearly show that while mouse IFN strongly inhibits virus release from these cells, human IFN is completely ineffective in this respect. These observations, together with those presented in the previous report (Aboud et al. I98O) , strongly suggest that the effect of IFN on MLV uncoating is not related to the conventional IFN-mediated antiviral state but rather results only from the binding of IFN to the cell surface. Binding of homologous IFN has been shown to produce several changes in the cell membrane (Lindahl et al. I974; Knight & Korant, 1977; Chang et al. i978 ). However, no data are available as to whether binding of heterologous IFN leads to similar membrane changes, or whether the membrane changes caused by homologous IFN require cellular protein synthesis. Therefore, it is unclear whether any membrane changes are required, besides IFN binding, for the inhibition of MLV uncoating. Further experiments are needed to clarify this aspect.
